Nuflor Minidose
Active substance
ATC code
Species
Cattle
Indications
Metaphylactic and therapeutic treatment of respiratory tract infections in cattle due to Mannheimia haemolytica, Pasteurella multocida and Histophilus somni susceptible to florfenicol. The presence of the disease in the herd should be confirmed before metaphylactic treatment.
Dose to be administered and administration route
Subcutaneous use: 40 mg/kg body weight (4 ml/45 kg) to be administered once only. Intramuscular use: 20 mg/kg body weight (2 ml/45 kg) to be administered twice 48 hours apart.
The injection should only be given in the neck. The dose volume given at any one injection site should not exceed 10 ml.
To ensure a correct dosage body weight should be determined as accurately as possible to avoid underdosing.
Swab septum before removing each dose. Use a dry, sterile needle and syringe. For 250 ml vials, do not broach the vial more than 25 times.
Adverse reactions
Cattle:
|
Very common (>1 animal / 10 animals treated): |
Injection site swelling1,4, Injection site inflammation 1,5, Injection site lesion1,5 |
|
Very rare (<1 animal / 10,000 animals treated, including isolated reports): |
Reduced food intake6; Soft stool2,6 |
1 After injection of the product at the maximum recommended volume of 10 mL per injection site
2 Transient
3 Lasting for some days
4 Lasting up to 61 days after subcutaneous and up to 24 days after intramuscular injection
5 Seen at necropsy and lasting for 37 days after intramuscular injection
6 Quick and complete recovery upon termination of treatment
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See also section “Contact details” of the package leaflet.
TRUSTED SOURCE
